What does CUSIP 22053A907 represent in this 13F holders report?

CUSIP 22053A907 is the security identifier for 22053A907 - QUINCE THERAPEUTICS INC - CALL used to aggregate holder disclosures.

How many institutions held 22053A907 - QUINCE THERAPEUTICS INC - CALL in Q4 2024?

No institutional holders were reported for 22053A907 - QUINCE THERAPEUTICS INC - CALL in Q4 2024; review adjacent reporting periods for trend context.

QUINCE THERAPEUTICS INC - CALL

CUSIP: 22053A907

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class: Equity / CALL
Price per share: $1.86
Number of holders: 0

Quarterly Holders Quick Answers

What is CUSIP 22053A907?
CUSIP 22053A907 identifies 22053A907 - QUINCE THERAPEUTICS INC - CALL in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2025
Previous quarter: Q3 2024

Recent filing periods for CUSIP 22053A907:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q4 2023 Q3 2023

QUINCE THERAPEUTICS INC - CALL

Q4 2024 13F Holders as of 31 Dec 2024

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of QUINCE THERAPEUTICS INC - CALL as of Q4 2024.